TARS — Tarsus Pharmaceuticals Inc

Ownership history in MPM BioImpact LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Tarsus Pharmaceuticals Inc (TARS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.32% (2025 Q3)
Avg. % of fund
2.93%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 328,869 -12,627 -3.7% 3.08% $26.9M $81.88
2025 Q3 UNCHANGED 341,496 — 0% 3.32% $20.3M $59.43
2025 Q2 INITIATED 341,496 — — 2.40% $13.8M $40.51
% of Fund (quarterly)    TARS price (monthly, adj. close)

Other funds also holding TARS

As of 2025 Q4 — sorted by position size

Paradigm Biocapital Advisors LP 3Y 5.35% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 4.81% Deep Track Capital, LP 3Y 4.39% GordonMD Global Investments LP 3.91% RTW INVESTMENTS, LP 3Y 7Y 2.74% Frazier Life Sciences Management, L.P. 3Y 1.6% Sands Capital Alternatives, LLC 3Y 1.34% Lisanti Capital Growth, LLC 3Y 7Y 1.25% HighVista Strategies LLC 3Y 7Y 1.13% Rock Springs Capital Management LP 3Y 7Y 1.09%
← Back to MPM BioImpact LLC Holdings